You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

rhabdoid tumors

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma, CNS Tumor, Sarcoma Trial in Columbus (Cabozantinib)

Recruiting
  • Neuroblastoma
  • +2 more
  • Columbus, Ohio
    Nationwide Children's Hospital
Dec 20, 2022

Study of Kidney Tumors in Younger Patients

Recruiting
  • Adult Cystic Nephroma
  • +24 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +247 more
Sep 2, 2022

Collecting and Storing Tissue From Young Patients With Cancer

Recruiting
  • Acute Lymphoblastic Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +68 more
Aug 4, 2022

Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)

Recruiting
  • Liver Cell Carcinoma
  • +7 more
  • CATCH T cells
  • +2 more
  • Houston, Texas
    Houston Methodist Hospital
Dec 19, 2022

Relapsed Solid Tumor, Refractory Solid Tumor Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)

Recruiting
  • Relapsed Solid Tumor
  • Refractory Solid Tumor
  • Phoenix, Arizona
  • +28 more
Dec 7, 2022

Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor Trial in Australia, Canada, United States (CLR 131)

Recruiting
  • Pediatric Solid Tumor
  • +7 more
  • CLR 131
  • Palo Alto, California
  • +6 more
Nov 30, 2021

Supratentorial Tumors, Malignant, Malignant Glioma, Glioblastoma Trial in Birmingham, Columbus (G207)

Active, not recruiting
  • Supratentorial Neoplasms, Malignant
  • +6 more
  • G207
  • Birmingham, Alabama
  • +1 more
Jun 1, 2022

Diffuse Intrinsic Pontine Glioma, High Grade Glioma, Embryonal Tumor Trial in Houston ((C7R)-GD2.CART cells, Cyclophosphamide,

Recruiting
  • Diffuse Intrinsic Pontine Glioma
  • +3 more
  • (C7R)-GD2.CART cells
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Feb 7, 2022

Neuroblastoma, Cancer Trial in Philadelphia (procedure, genetic, other, behavioral, drug)

Terminated
  • Neuroblastoma
  • Cancer
  • Biopsy
  • +12 more
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Jan 31, 2023

Solid Tumor Trial in United States (Sirolimus, Cyclophosphamide, Etoposide)

Recruiting
  • Solid Tumor
  • Atlanta, Georgia
  • +4 more
Feb 8, 2022

Cancer Trial in United States (Sirolimus, Celecoxib, Etoposide)

Recruiting
  • Cancer
  • Phoenix, Arizona
  • +5 more
Oct 28, 2021

Samples From Malignant Rhabdoid Tumor of Kidney or Atypical

Withdrawn
  • Childhood Atypical Teratoid/Rhabdoid Tumor
  • Rhabdoid Tumor of the Kidney
  • Laboratory Biomarker Analysis
  • Philadelphia, Pennsylvania
    Childrens Oncology Group
Aug 3, 2018

Drug Sensitivity and Mutation Profiling

Recruiting
  • Ewing Sarcoma
  • +6 more
    • Miami, Florida
      Nicklaus Children's Hospital
    Aug 5, 2022

    Adult Kidney Wilms Tumor, Beckwith-Wiedemann Syndrome, Childhood Kidney Wilms Tumor Trial in Worldwide (biological, drug,

    Active, not recruiting
    Has Results
    • Adult Kidney Wilms Tumor
    • +10 more
    • Dactinomycin
    • +4 more
    • Birmingham, Alabama
    • +168 more
    Mar 23, 2022

    Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

    Active, not recruiting
    • Brain and Central Nervous System Tumors
    • +9 more
    • DNA analysis
    • +4 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Oct 28, 2021

    An Observational Study on Epithelioid Sarcoma

    Recruiting
    • Epithelioid Sarcoma
    • Treatment for Epitheloid Sarcoma
    • Bari, BA, Italy
    • +12 more
    Oct 29, 2021

    Solid Tumors Trial in Worldwide (Cobimetinib)

    Completed
    Has Results
    • Solid Tumors
    • Little Rock, Arkansas
    • +16 more
    Sep 14, 2022

    Gastrointestinal Cancer Screening Based on Patient-related Risk

    Not yet recruiting
    • Malignant Tumor of Digestive Tract
    • Risk Factors
      • Xi'an, Shaanxi, China
        Xijing of Digestive Diseases
      Nov 1, 2023

      Her2-positive/Low-expression Urinary and Digestive Tract Tumors Trial in Beijing (BL-M07D1)

      Not yet recruiting
      • Her2-positive/Low-expression Urinary and Digestive Tract Tumors
      • Beijing, Beijing, China
        Cancer Hospital, Chinese Academy of Medical Sciences
      Sep 8, 2023

      Solid Tumor, Adult Trial in Beijing (Vaccine)

      Not yet recruiting
      • Solid Tumor, Adult
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Aug 3, 2023

      Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)

      Active, not recruiting
      Has Results
      • Brain and Central Nervous System Tumors
      • Induction Chemotherapy
      • +3 more
      • Palo Alto, California
      • +5 more
      Nov 29, 2022

      Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

      Not yet recruiting
      • Adrenal Cortical Carcinoma
      • +3 more
      • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
      • Shanghai, Shanghai, China
        Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
      Nov 19, 2023

      Germ Cell Tumor and Testicular Tumor DNA Registry

      Recruiting
      • Germ Cell Tumor
      • Testicular Tumor
      • Questionnaires
      • sample of blood or saliva
      • Basking Ridge, New Jersey
      • +7 more
      Jan 31, 2023

      Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

      Completed
      • Urinary Bladder Cancer
      • +4 more
      • Neutrophil to lymphocyte ratio
      • Cairo, Egypt
        Ain Shams university
      Jul 15, 2023

      Doppler Ultrasound and CT Versus Laparoscopy in Assessment of

      Recruiting
      • Ovarian Cancer
      • Laparoscopy
      • Mansoura, Dakahlia, Egypt
        Mansoura University Hospital
      Oct 25, 2023